VentureRadar

 

Location: United Kingdom

Founded in 2011

Private Company


"VentureRadar helps organisations innovate and generate new growth by connecting them to the emerging technologies and expertise that can solve their challenges. We discover innovative companies from across the globe using our Company Discovery Engine, which trawls the web to harvest and aggregate company information at a scale, speed and efficiency that hasn’t previously been possible. By structuring and analysing this information we are able to accurately match our clients needs with the start-ups, SMEs and other innovators that have the skills our clients need. We work directly with corporations and also with service providers (such as open innovation agencies, outsourced R&D consultants, and traditional crowd-sourcing companies) to provide them with our intelligent company discovery capabilities."
Description Source: Community submitted data
Keywords: Life Sciences; Biologics; Healthtech; Sars-Cov-2 Vaccine; Cancer; Melanoma; Immunotherapy; Diagnostics; Dna; Rna; Peptide Therapies; Vaccines; Biotech

Updates


Website Traffic Trend
Business InsighT
01 Dec 2020
Website traffic has increased in the past 3 months, up from a ranking of 676,733 to 376,314.
Source:
COVID-19 vaccine tracker - London School of Hygiene & Tropical Medicine
Research Report
20 Sep 2020
[BioNTech; Fosun Pharma; Pfizer] listed among those developing/researching a COVID-19 Vaccine / Vaccine type: RNA
Source: vac-lshtm.shinyapps.io
BIO-Europe Spring 2020
Conference
23 Mar 2020
Source:
Milken Institute Tracker of COVID-19 Vaccine developers/researchers
Research Report
20 Mar 2020
BioNTech/Fosun Pharma/Pfizer listed among those developing/researching a COVID-19 Vaccine
Source: milkeninstitute.org
Venture-funding News
Equity Funding
08 Jul 2019
BioNTech Raises USD$325M in Series B Financing
Source: finsmes.com
Website Traffic Trend
Business Insight
30 Jun 2019
Website traffic has increased in the past 3 months, up from a ranking of 475,997 to 238,327.
Source:
Website Traffic Trend
Business Insight
30 Apr 2019
Website traffic has increased in the past 3 months, up from a ranking of 475,997 to 238,327.
Source:
BIO-Europe Spring 2019
Conference
25 Mar 2019
One of Participating Companies
Source: events.ebdgroup.com
Venture-funding News
Equity Funding
04 Jan 2019
Sanofi invests €80M in BioNTech as cancer mRNA hits clinic
Source: fiercebiotech.com
IO-Europe 2018
Conference
05 Nov 2018
One of Participating Companies
Source: events.ebdgroup.com
Website Traffic Trend
Business Insight
30 Sep 2018
Website traffic has increased in the past 3 months, up from a ranking of 475,997 to 238,327.
Source:
Venture-funding News
Equity Funding
21 Jan 2018
BioNTech AG Raises Series A Funding
Source: dngeek.com
Venture-funding News
Equity Funding
01 Mar 2017
Spark Therapeutics' vision-loss gene therapy to cost $850,000 per patient | Reuters
Source: reuters.com
The STEP Award (2011)
Award
29 Nov 2011
Category Winner: Finances
Source: The STEP Award (2011)

Funding Signals


VENTURE FUNDED

Venture-funding NewsVenture-funding NewsVenture-funding News

Website Archive


2021
2022
2023
2024
2025
Internet Archive snapshots for |
The archive allows you to go back in time and view historical versions of the company website
The site was first archived on
Source:
The earliest website snapshot may be older than the company, if for example the website was previously used by another owner.
VentureRadar Score

Register now to view this profile

Free Sign-up

Sub-Scores
Social Proof
980
Website Traffic
900
Auto Analyst Score
n/a
Popularity on VentureRadar
1000
Website Popularity
Low Traffic Sites
Low
High Traffic Sites
High
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Open PageRank: 77,927 | ventureradar.com
Auto Analyst Score
75
Auto Analyst Score: 75 | ventureradar.com
VentureRadar Popularity
High
VentureRadar Popularity: High
The popularity score combines profile views, clicks and the number of times the company appears in search results.

Free Sign-up for VentureRadar access

or






By continuing, you agree to VentureRadar's Terms of Service, Privacy Policy and Cookie Policy.

To continue, please confirm you are not a robot